Vitronectin in atherosclerotic disease.

@article{Ekmeki2006VitronectinIA,
  title={Vitronectin in atherosclerotic disease.},
  author={Ozlem Balci Ekmekçi and Hakan Ekmekçi},
  journal={Clinica chimica acta; international journal of clinical chemistry},
  year={2006},
  volume={368 1-2},
  pages={
          77-83
        }
}
Atherosclerosis is characterized by the development of an intimal thickening that contains monocytes, T lymphocytes, and smooth muscle cells within an accumulation of lipid and extracellular matrix proteins. Vitronectin is a plasma glycoprotein implicated as a regulator of diverse physiological process, including blood coagulation, fibrinolysis, pericellular proteolysis, complement dependent immune responses, and cell attachment and spreading. Because of its ability to bind platelet… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Similar Papers

Loading similar papers…